The New York State Department of Health issued health advisors on Wednesday regarding the emergence of new tensions MPOX (formerly Monkeypox).
The first case of MPOX clade IB in New York was confirmed in a symptomatic individual who recently traveled from Africa.
The current risk to the public remains low, the department says, and there are currently no known known cases of the strain community in New York.
Is MPOX the next covid? Infectious disease experts are tackling the potential of a pandemic
State Health Director Dr. James McDonald shared that infected individuals are caring for doctors and are isolated “up to the full resolution of symptoms.”
“There is no known local transmission of MPOX clade IB in communities where individuals live within New York,” he said in a statement.
The first case of MPOX clade IB in New York was confirmed in a symptomatic individual who recently traveled from Africa. (Yasuyoshi chiba/afp via Getty Images)
McDonald’s added that the Jynneos vaccine, the two-dose preventative vaccine series of MPOX, is “expected to be effective” against the new strain.
“[It is] He said that the permanent order signed last year will be available to individuals at risk.
Visit us for more health articles www.foxnews.com/health
The health department added in its advisory that individuals should contact their local pharmacy or health care provider. Vaccine availability They will continue to “keep and maintain the situation.”
MPOX is “rarely fatal,” according to the department, but can be dangerous not only for elderly people, young children and pregnant women, but also for people with immunocompromised conditions.
The Jynneos vaccine, a two-dose preventative vaccine series for MPOX, is “expected to be effective” against this new strain. (Patrick T. Fallon/AFP Getty Images)
Symptoms include swollen lymph nodes, fever, sore throat, headaches, as well as rashes that progress to “painful skin lesions.” Back painlow energy and muscle pain, departments are listed.
It can be “highly likely to spread” until these lesions are slightly covered. In other words, infected individuals are encouraged to isolate until new skin forms at the lesion site.
“There’s no immediate risk to the public.”
MPOX may expand The department said through close intimate contact with pain, scabs or rashes, and through the respiratory fluid, saliva or mucus of an infected person.
Experts recommend that those planning to travel to areas with reported cases of MPOX should consider getting vaccinated with two doses of Jynneos.
Click here to sign up for our health newsletter
Dr. Miles Druckman, global medical director of International SOS in California, told Fox News Digital that the stock has been reported in several countries in central and eastern Africa.
According to health officials, MPOX can cause rashes that progress to “painful skin lesions.” (istock)
“Other countries also report cases related to Clade I travel, including Belgium, Canada, China, France, Germany, India, Ireland, Oman, Pakistan, South Sudan, Sweden, Thailand, the United Kingdom and Zimbabwe. I understand,” he pointed out.
“Cases of this strain are expected due to ongoing outbreaks in multiple countries and risks associated with global travel.”
“It’s important to recognize that this stock is expected. Continuous outbreaks Risks related to travel across multiple countries and globally. ”
MPOX can be infected for up to four days before symptoms develop, but according to Druckman, it is the most contagious as symptoms appear until about 2-4 weeks later.
Click here to get the Fox News app
Experts emphasized that vaccinations are recommended for high-risk individuals, such as healthcare workers with high exposure and those with weakened immune systems.
“MPOX prevention mainly involves vaccination and observing skin-to-skin contact with others, especially those with symptoms or visible development, and good personal hygiene and frequent washing of hands. I’m avoiding it,” he added.
